JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balbin, M.
Right arrow Articles by Abrahamson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balbin, M.
Right arrow Articles by Abrahamson, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 269, Issue 37, 23156-23162, 09, 1994

Structural and functional characterization of two allelic variants of human cystatin D sharing a characteristic inhibition spectrum against mammalian cysteine proteinases

M Balbin, A Hall, A Grubb, RW Mason, C Lopez-Otin and M Abrahamson
Department of Clinical Chemistry, University of Lund, University Hospital, Sweden.

Human cystatin D is a novel member of the cystatin superfamily of cysteine proteinase inhibitors present in saliva and tears. Two alleles of the cystatin D gene (CST5), encoding protein variants with either Cys or Arg as residue 26 in their 122-residue polypeptide chains, are present in the population. Expression of the two alleles was investigated by immunochemical analyses of the secreted cystatin D in saliva from individuals homozygous for each of the two alleles, with results demonstrating that both are expressed at similar levels. The inhibitory characteristics of the two cystatin D variants were studied, by determination of dissociation equilibrium constants (Ki) for their complexes with papain and with the mammalian cysteine proteinases, cathepsins B, H, L, and S. The results demonstrate that 1) cystatin D has a characteristic inhibition profile since it does not inhibit cathepsin B (Ki > 1 microM), and when compared to cystatin C and all other known cystatins it is a much poorer inhibitor of cathepsin L (mean Ki 25 nM) but binds cathepsin H and S relatively tightly (mean Ki values of 8.5 and 0.24 nM, respectively); and 2) the inhibitory activities of the two cystatin D variants are not significantly different, demonstrating that the presence of an extra cysteine residue in the cystatin D molecule affects neither the stability nor the functional activity of the inhibitor, thus explaining the widespread distribution of the Cys26-cystatin D encoding allele in the population. The inhibitory properties displayed by cystatin D suggest that it has a function in saliva as inhibitor of either endogenous or exogenous enzymes with cathepsin S- or H-like properties.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. W. Schuttelkopf, G. Hamilton, C. Watts, and D. M. F. van Aalten
Structural Basis of Reduction-dependent Activation of Human Cystatin F
J. Biol. Chem., June 16, 2006; 281(24): 16570 - 16575.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Alvarez-Fernandez, Y.-H. Liang, M. Abrahamson, and X.-D. Su
Crystal Structure of Human Cystatin D, a Cysteine Peptidase Inhibitor with Restricted Inhibition Profile
J. Biol. Chem., May 6, 2005; 280(18): 18221 - 18228.
[Abstract] [Full Text] [PDF]


Home page
Crit. Rev. Oral Biol. Med.Home page
D.P. Dickinson
SALIVARY (SD-TYPE) CYSTATINS: OVER ONE BILLION YEARS IN THE MAKING--BUT TO WHAT PURPOSE?
Crit. Rev. Oral. Biol. Med., November 1, 2002; 13(6): 485 - 508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ni, M. A. Fernandez, L. Danielsson, R. A. Chillakuru, J. Zhang, A. Grubb, J. Su, R. Gentz, and M. Abrahamson
Cystatin F Is a Glycosylated Human Low Molecular Weight Cysteine Proteinase Inhibitor
J. Biol. Chem., September 18, 1998; 273(38): 24797 - 24804.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Halfon, J. Ford, J. Foster, L. Dowling, L. Lucian, M. Sterling, Y. Xu, M. Weiss, M. Ikeda, D. Liggett, et al.
Leukocystatin, A New Class II Cystatin Expressed Selectively by Hematopoietic Cells
J. Biol. Chem., June 26, 1998; 273(26): 16400 - 16408.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ni, M. Abrahamson, M. Zhang, M. A. Fernandez, A. Grubb, J. Su, G.-L. Yu, Y. Li, D. Parmelee, L. Xing, et al.
Cystatin E is a Novel Human Cysteine Proteinase Inhibitor with Structural Resemblance to Family 2Cystatins
J. Biol. Chem., April 18, 1997; 272(16): 10853 - 10858.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hall, K. Håkansson, R. W. Mason, A. Grubb, and M. Abrahamson
Structural Basis for the Biological Specificity of Cystatin C
J. Biol. Chem., March 10, 1995; 270(10): 5115 - 5121.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1994 by the American Society for Biochemistry and Molecular Biology.